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Introduction
Congenital neutropenia represents a heterogeneous group of disorders whose molecular etiology and pathophysiology remains enigmatic in most cases. Over the last few years, heterozygous mutations in the gene encoding neutrophil elastase have been associated with cyclic 1 and congenital 2 neutropenia, yet insights into the pathophysiology remain scarce.
Recently, aberrant vesicular trafficking of endosomes has been proposed as one potential mechanism accounting for decreased neutrophil numbers. 3 Intracellular protein sorting and trafficking are controlled by means of coat proteins. 4 The adaptor protein-3 (AP-3) complex facilitates trafficking of vesicles from the trans Golgi network and/or endosomal compartments. 5, 6 The AP-3 complex is a heterotetramer consisting of two big subunits, β3A (140 kDa) and δ3 (160 kDa), a medium subunit μ3A (47 kDa) and a small σ3A subunit. Three of the four subunits are also expressed as neuronal isoforms (β3B, μ3B, σ3B). AP-3 belongs to the family of cytosolic adaptor complexes and is involved in intracellular protein sorting and vesiculation. Details of the function of AP-3 in mammalian cells are poorly understood. Recent work indicates that AP-3 is associated with budding profiles evolving from a tubular endosomal compartment. 7 Various animal models confirm the significance of AP-3 in endosomal trafficking.
Mutations in the fruitfly genes coding for the subunits of AP-3 result in defective pigmentation of the eyes. 8 The autosomal recessive mouse mutation pearl shows abnormal platelet dense granules, hypopigmentation, and abnormal lysosomal secretion, and is associated with mutations in the β3A subunit gene (Ap3b1) of the AP-3 adaptor complex. 9 Similar findings are seen in an engineered Ap3b1 knockout mouse strain. 10 Interestingly, in contrast to mice whose neutrophil counts appear to be normal, dogs with mutations in AP3B1
suffer from cyclic neutropenia. 3 These animal models indicate that AP-3 deficiency results in increased surface expression of lysosomal proteins.
4
In humans, mutations in AP3B1 cause a complex phenotype known as HermanskyPudlak syndrome 11 (HPS, OMIM 203300) type 2 (HPS2), which was first demonstrated by Dell'Angelica et al. 12 To date, four human patients with HPS2 have been described in the literature. [12] [13] [14] [15] In general, Hermansky-Pudlak syndrome patients suffer from hemorrhagic diathesis due to prolonged bleeding time and tyrosinase-positive oculocutaneous albinism. Congenital neutropenia appears to be a distinguishing feature of HPS2. Some patients develop lung fibrosis and inflammatory colitis over time, others show defects in CD8 + T cell-mediated cytotoxicity. 15 In all cases reported so far, HPS appears to be inherited as a monogenic, autosomal recessive disease. However, it is a genetically heterogeneous disorder caused by mutations in eight known genes. 12, [16] [17] [18] [19] [20] [21] . For HPS type 1, which is by far the most common form of HPS in humans, there is also allelic heterogeneity leading to a variety of clinical manifestations. 16 Like AP3B1, most of the HPS-causative genes were identified with the aid of mouse models. Since at least 16 mouse mutants have been shown to mimic the phenotype of HPS, 22 it is likely that some of their human orthologs will be found mutated in human HPS patients in the future.
In this paper, we report on genetic investigations of a consanguineous pedigree first reported by Kotzot et al. in 1994. 23 In this family, two cousins show a phenotype associating coarse facial features, hypopigmentation, mild mental retardation, splenomegaly, neutropenia and thrombocytopenia.
In view of this unusual clinical presentation, we took a positionally unbiased approach and performed a genetic linkage study across the genome. We identified a homozygous genomic deletion in AP3B1 and functionally characterized AP-3-deficient fibroblasts and neutrophils.
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Patients, Materials and Methods

Patients
Blood samples and skin biopsies were taken upon informed consent. The study was approved by the Internal Review Boards at Hannover Medical School and the University of Freiburg.
Marker selection and genotyping
For the initial genome scan, 261 polymorphic markers (Invitrogen, Karlsruhe, Germany) were genotyped on genomic DNA extracted from whole blood of eleven individuals according to the published conditions. Two additional polymorphic markers on chromosome 5 were later genotyped to better define the upper boundary of the linkage interval, and to prove that the AP3B1 gene is inside the linkage interval.
PCR products were analyzed on an ABI 377 sequencer (PE Applied Biosystems, Foster City, USA) with the COLLECTION and ANALYSIS software packages (PE Applied Biosystems). Allele sizes were determined using the program GENOTYPER (PE Applied Biosystems).
Genetic linkage analysis
Genetic linkage analysis computations were done with FASTLINK 24,25 for 1 and 2 markers, and Superlink 26,27 for more markers. A fully penetrant autosomal recessive inheritance model was used. The disease allele frequency was set to 0.001 and marker allele frequencies were set all equal due to the small number of individuals genotyped.
Mutation detection
The candidate gene AP3B1 on chromosome 5q was analyzed by direct sequencing of genomic DNA. Results were confirmed by cDNA sequencing. The cDNA of the affected individual #30 was amplified with eight primer sets. For cDNA amplification of exons 11 -16, the forward-primer (5'-AAAGAAAGGGGATGTTTGAACCT) and the reverse-primer (5'-TTCGGAACAATAAGCTGCCTAATA) were used at an annealing temperature of 53° C.
Sequencing was performed with the forward-primer at an annealing temperature of 54° C. To detect CD63 at the plasma membrane, fibroblasts of the AP-3 -deficient patient #30
and two unrelated donors were incubated stained with FITC-conjugated anti-CD63 (clone H5C6) and a corresponding isotype control antibody (BD Biosciences).
Flow cytometry was performed using a FACSCalibur flow cytometer (BD Biosciences and anti-σ3A (1:250, BD Biosciences). AP3-δ and -β were detected on a 7% gel, AP3-σ was detected on a 10% gel.
The following antibodies were used to detect neutrophil proteins: anti-MPO (1:1000;
Abcam, Hiddenhausen, Germany), anti-PR3 (1:300; Santa Cruz, Heidelberg, Germany), anti-HNE (1:300; Merck Biosciences Calbiochem; Schwalbach/TS, Germany), anti-MMP9
(1:300; Acris, Hiddenhausen, Germany), and anti-GAPDH (1:1000, Santa Cruz).
Cell extracts were separated in SDS-PAGE, blotted and analyzed with Kodak 
Electron microscopy
Skin biopsies from patient #30 and two unrelated normal donors were fixed with 2.5% glutaraldehyde (Polysciences, Warrington, USA) in 0.1 M sodium cacodylate, pH 7.3 (MerckSchuchardt, Hohenbrunn, Germany) and postfixed with 2% osmium tetroxide (Polysciences, Eppelheim, Germany) in the same buffer. After dehydration the specimens were embedded in Epon resin. Thin sections were stained with uranyl acetate and lead citrate. For personal use only. by on . www.bloodjournal.org From sodium cacodylate, pH 7.3. In addition, primary granulocytes were analyzed directly after hypotonic erythrocyte lysis. Electron microscopy was performed using a Philips electron microscope 301.
Neutrophil studies
For neutrophil studies, freshly purified granulocytes from patient #30 and two healthy individuals were used. In some experiments, granulocytes were differentiated in vitro from purified CD34
+ cells in the presence of recombinant human G-CSF and GM-CSF (AMGEN, Thousand Oaks, California, USA), following a previously published protocol. 28 Primary granulocytes were purified by gradient centrifugation over Ficoll Paque and consecutive hypotonic erythrocyte lysis, yielding a purity of >95%.
For chemotaxis experiments, neutrophils were first starved in RPMI 1640
supplemented with 1% BSA (Carl Roth, Karlsruhe, Germany) at pH 7.0 for 4 hrs. Chemotaxis was assessed in duplicates in fibronectin-coated 0.3 μm pore size transwell migration plates (Corning ® / Sigma-Aldrich, Munich, Germany) as previously described. 29 The number of migrated cells with respect to input cells was analyzed by flow cytometry after addition of 50,000 uniform dyed microspheres (Bangs Laboratories Inc., Fishers, IN, USA) to assure volume independent acquisition. The inwells were flushed and controlled for the absence of residual adherent cells.
Phagocytosis was evaluated using FITC labeled K12 E. coli bacteria (Molecular Probes / Invitrogen, Karlsruhe, Germany). 5x10 5 neutrophils were exposed to inactivated K12
E. coli at a ratio of 1:50 in 100 μl of RPMI 1640 supplemented with 10% FCS and 10mM
HEPES buffer pH 7.4 and cultured at a temperature of 37°C. Uptake of bacteria was analyzed by flow cytometry after quenching extracellularly attached bacteria with 0.4% trypan blue solution (Gibco / Invitrogen, Karlsruhe, Germany) at 4°C.
E. coli killing was assessed according to a previously described protocol. 30 In this assay, killing of a mutant strain of Escherichia coli (E. coli ML-35, kindly provided by galactosidase activity. The E. coli mutant has no lactose permease but expresses β-galactosidase. Upon perforation of the bacterial envelope, β-galactosidase cleaves the artificial substrate ortho-nitrophenyl-β-D-galactopyranoside.
Results
Clinical phenotype
We investigated the molecular etiology of congenital neutropenia in two patients (age 15 and 21 years), offspring of a consanguineous Turkish family (Fig. 1A) . Their complex phenotype, associating congenital neutropenia, thrombocytopenia, mild developmental delay, coarse facial features, splenomegaly, and hypopigmentation, has been reported previously. 23 Despite remarkably low neutrophil counts (ranging from 0-500/μl), both patients had a relatively benign clinical course and did not suffer from life-threatening infections. The most prominent finding was severe dental decay and aggressive periodontitis (Fig. 1B) . Microbiological analysis revealed presence of Porphyromonas gingivalis, Tannerella forsythensis, and
Treponema denticola, a microbial spectrum usually associated with severe periodontitis.
Patient #29 suffered from recurrent skin abscesses, patient #30 has had two episodes of pneumonia to date. Temporary administration of G-CSF enhanced the peripheral neutrophil counts to normal levels, an effect that was not sustained due to poor compliance.
There was no evidence of prolonged bleeding. Patient #30 tolerated circumcision without hemorrhagic complications. Both patients showed splenomegaly and thrombocytopenia ranging from 50,000 to 150,000 platelets/μl. The ultrastructure of peripheral blood thrombocytes revealed immature dense granules (not shown). A bone marrow aspirate and biopsy on patient #30 revealed normal cellularity and complete maturation of all lineages without dysplastic changes (not shown).
Both patients showed decreased visual acuity, photophobia and nystagmus associated with decreased pigmentation of the eye fundus (not shown). Due to aberrant melanosome maturation in melanocytes, immature melanosomes were transported to keratinocytes and completely degraded in large phagosomes inside the basal layer of the epidermis (Fig. 1C) , as was evidenced in transmission electron microscopy (TEM) studies.
Immunological phenotype
Immunological investigations revealed normal serum levels of IgG, IgM, and IgA. Both patients mounted specific antibodies in response to tetanus and polio vaccines but failed to generate antibodies against mumps and rubella. Immunophenotyping of peripheral blood cells showed normal numbers of B and T cells (Supplementary Table 1 ). However, CD3 -CD56 + NK cells were reduced in numbers (Fig 2A) . The decrease in CD56 + cells prompted us to also assess the rare subpopulation of NKT cells. We stained lymphocytes from patient #29 and #30
with monoclonal antibodies against Vβ11 and Vα24 or CD3 and 6B11, respectively, and determined the absolute number of NKT cells in peripheral blood. Interestingly, compared to healthy family members, the numbers of NKT cells were significantly reduced in patient #29
and #30 ( Fig. 2B and C) .
Even though some clinical features such as hypopigmentation and congenital neutropenia raised the suspicion of AP-3 deficiency, 13 other characteristics such as developmental delay, splenomegaly and thrombocytopenia could not be easily reconciled with this diagnosis.
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Genome-wide linkage analysis
In light of the atypical clinical presentation of this family, we carried out a genome-wide screen to localize the genetic cause. The only place in the genome where multiple adjacent markers had LOD scores > 1 was on chromosome 5q (see Table 1 ). The positively scoring markers from D5S1501 (at 78.5Mb from 5ptel) through D5S1505 (119.1Mb from 5ptel) indicated a huge interval where the affected individuals are homozygous and the markers segregate perfectly with the disease. However, AP3B1 is located at approximately 77.3Mb, which is between the unlinked marker D5S2500 and the first linked marker D5S1501 (Fig.   3A) . Therefore, we genotyped two additional markers, D5S424 (76.2Mb) (Fig. 3A) and D5S2041 (76.7Mb), to show that AP3B1 is positioned inside the interval of perfect segregation. The peak multipoint LOD score using the 6 positively-scoring markers in Table 1 is 3.30.
Mutation detection and DNA analysis
We The deleted interval spanned 8,168 bp including a big part of intron 14, the complete exon 15, and a small part of intron 15 (Fig. 3C) . Loss of exon 15 results in the absence of the aminoacids 491 -550 while preserving the reading frame. Therefore, it is expected that an intact, albeit defective AP3B1 protein is translated in the patient's cells.
Protein analysis
According to the GenBank annotation of AP3B1 (NP_003655), the functional adaptin domain, which is shared by multiple proteins in different adaptor complexes, spans amino acids 39-560, ending in exon 16. Therefore, sequence analysis suggests that skipping exon 15
at positions 491-550 is likely to have deleterious consequences. and controls (not shown). However, intact assembly of the AP-3 complex was severely disturbed. Protein extracts from fibroblasts obtained from patient #30 showed decreased concentrations of the AP-3 β,δ, and σ subunits when compared to fibroblasts from a healthy donor (Fig. 4A) . Furthermore, AP3B1-deficient fibroblasts did not react with anti-δ polyclonal antibodies in immunofluorescence studies (Fig. 4B) , suggesting that the deletion of AP3B1 exon 15 prevents proper assembly of the AP-3 complex.
It has been previously shown that the AP-3 complex interacts with the tyrosine-based signals of the tetraspanin molecule CD63 and that in the absence of AP3B1 lysosomal missorting leads to increased cell surface expression of CD63. 12 In line with previous studies, we documented that CD63 expression at the cell surface was enhanced (Fig. 4C) , thus strengthening the concept that a deletion of exon 15 of AP3B1 functionally compromises the AP-3 complex. Taken together, these data suggest that exon 15 of AP3B1 is critically involved in the stabilization and function of the AP-3 complex.
Neutrophil function
We reasoned that a defective lysosomal compartment might contribute to neutropenia and potentially neutrophil dysfunction. We performed transmission electron microscopy on purified neutrophils from our patients and healthy donors. Compared to healthy donors, AP-3-deficient neutrophil granulocytes showed uniformly marked alterations in azurophilic and specific granules: in contrast to a distinct compartmentalization of specific and azurophilic granules in normal neutrophils, AP-3-deficient neutrophils showed a disorganized pattern characterized by distorted shapes and a less well-defined density spectrum of their granules (Fig. 5A-B) . To assess the function of neutrophil granulocytes, we focused our investigations (Fig. 5F ).
Next, we evaluated the capacity to ingest bacteria. Neutrophil granulocytes from patient #30 and from two healthy control individuals were incubated with FITC-labeled Fcconjugated E. coli bacteria. Phagocytosis was measured after 20, 40, and 60 minutes by FACS. As shown in Fig. 5G , the patient's neutrophils showed similar phagocytic activity compared to the control cells, suggesting that the Fc-mediated phagocytosis is not perturbed in the absence of the AP-3 complex. To determine the killing activity of AP-3-deficient neutrophils, we used a fluorimetric assay allowing to visualize β-galactosidase activity upon fusion of the phagolysosome. However, AP-3-deficient neutrophils were as effective as control neutrophils in killing E. coli bacteria (Fig. 5H) . Similar results were seen when the phagolysosomes upon ingestion of pathogenic pseudomonas bacteria were compared between normal and AP-3-deficient neutrophils by means of electron microscopy ( Fig. 5C-D) . Thus, despite marked alterations in the lysosomal organelles, no defective neutrophil function could be documented.
In neutropenic dogs, mutations in the AP3B1 gene cause perturbed intracellular trafficking and reduced abundance of neutrophil elastase. 3 To assess the global expression pattern of neutrophil granule contents, we performed a series of Western blots, comparing cell extracts from one patient (#30) and two healthy controls, respectively. As shown in Fig. 5E , the patient's cells showed comparable levels of myeloperoxidase and proteinase-3 levels, while abundance of neutrophil elastase and matrix metalloproteinase 9 (gelatinase) was reduced.
Discussion
We here describe two novel HPS2 patients and determine, for the first time, a homozygous genomic exon deletion as the molecular cause for this rare disorder. All previously reported human patients as well as the affected dogs have nonsense mutations. Furthermore, in contrast to the previously published four cases, our patients show novel clinical features such as splenomegaly, thrombocytopenia, and developmental delay, suggesting that the clinical spectrum of AP-3 deficiency might be more variable than previously described. Another interesting novel feature of our patients is the paucity of NK and NKT cells. Finally, we provide evidence that neutrophil function appears to be intact despite disorganized lysosomal compartments.
The deletion of exon 15 completely abrogates proper assembly and/or stability of the AP-3 complex. It has previously been shown in mice that complete deficiency of β3A results in complete lack of μ3, the AP-3 subunit to which β3A binds directly, 5 and in reduced levels of the δ and σ subunits. 10 Similarly, human HPS2 patients characterized by compound heterozygous mutations resulting in residual AP3B1 expression or in complete β3A deficiency showed decreased levels of σ3 and δ3, 13 suggesting that normal β3A chain is critically important to stabilize the heterotetrameric AP-3 complex. Peden et al. have recently undertaken a study to delineate functional domains controlling protein configurations in the AP-3 complex 7 by using a complementation assay in β3A deficient cells obtained from the pearl mouse. Whereas the adaptin domain is important for assembly into heterotetrameric complexes, the C-terminal hinge and ear domains mediate the function of AP-3. Therefore, the μ chain could not be detected by Western blotting, while the σ and δ subunits appeared reduced. Thus, our patients provide an "in vivo" model of an adaptin domain deletion rendering the AP-3 β chain incapable of forming the AP-3 complex.
For personal use only. by on . www.bloodjournal.org From AP-3 is critically involved in the biogenesis of specialized endosomal organelles referred to as lysosome-related organelles. 31, 32 Previous in vitro experiments have shown that in AP-3-deficient melanosomes, tyrosinase accumulates inappropriately in vacuolar and multivesicular endosomes, thus preventing the full maturation of melanosomes. 33, 34 Here, we provide evidence that the incomplete maturation of melanosomes is seen in humans in vivo.
Immature melanosomes are degraded in large phagolysosomes of basal keratinocytes, resulting in hypopigmented skin and retina.
Neutrophil granulocytes represent a cellular compartment that contains a specialized lysosomal compartment. Upon engulfing exogenous particles, phagosomes are destined to fuse with lysosomes to degrade phagocytosed material. So far, the role of AP-3 in the formation of phagolysosomes has not been addressed. Interestingly, AP-3 deficiency leads to neutropenia in humans (congenital neutropenia) 12 and dogs (cyclic neutropenia), 3 but not in mice. 10 The reason for this species specificity remains unknown. Furthermore, the exact pathophysiology of neutropenia in AP-3 deficiency is only beginning to be unraveled.
Horwitz has presented an elegant hypothesis that offers an interesting interpretation of the puzzling question of why AP-3-deficient individuals might suffer from neutropenia.
primary peripheral blood neutrophils. propensity to fatal EBV infections, the four previously published patients with HPS2 and the two novel cases in our study were not particularly prone to viral infections, suggesting that NKT cells may not play a critical role in antiviral immune defense.
In summary, our report extends the clinical and molecular phenotype of HPS2 and provides further insights into the role of the AP-3 complex for the innate immune system. For personal use only. by on . www.bloodjournal.org From
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